Torrent Pharmaceuticals will participate in a series of investor meetings across September 2026. The company disclosed the schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The management team will engage with investors through both group presentations and one-on-one sessions. These interactions provide a platform for discussing business strategy and operational updates.

Meeting Schedule

The company has scheduled three key investor engagements over the next two weeks. All meetings are subject to change due to exigencies.

Chintan Trivedi, Company Secretary, signed the disclosure on September 10, 2026. The company requested stock exchanges to take note of the schedule.

Torrent Pharmaceuticals will participate in an investor meet on August 14, 2026, as part of the Emkay Confluence 2026 event in Mumbai. The company disclosed the schedule in a filing with the Bombay Stock Exchange and the National Stock Exchange of India Ltd on August 11, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The engagement is designed to provide stakeholders with direct access to company management through both group presentations and individual consultations. This interaction allows investors to discuss strategic updates and operational performance directly with executives.

Meeting Schedule

The details of the upcoming investor interaction are outlined below:

The company noted that the schedule is subject to change due to any exigencies on the part of the company or the investors.

Regulatory Disclosure

The announcement was signed by Chintan Trivedi, Company Secretary of Torrent Pharmaceuticals Limited. The filing serves as a formal intimation to the exchanges regarding the company's compliance with mandatory disclosure norms for investor interactions.